自体富血小板血浆治疗肛瘘的有效性和安全性:系统回顾和荟萃分析。

Annals of Saudi medicine Pub Date : 2024-07-01 Epub Date: 2024-08-01 DOI:10.5144/0256-4947.2024.264
Yuanhui Xu, Lin Ma, Keliang Jia, Xiaoling Wu, Chang Ge
{"title":"自体富血小板血浆治疗肛瘘的有效性和安全性:系统回顾和荟萃分析。","authors":"Yuanhui Xu, Lin Ma, Keliang Jia, Xiaoling Wu, Chang Ge","doi":"10.5144/0256-4947.2024.264","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>This study aimed to determine the efficacy and safety of autologous PRP in anal fistula.</p><p><strong>Methods: </strong>The search was done in electronic databases such as; PubMed, Scopus, Google Scholar, Embase, and Cochrane Library. The outcomes investigated in this study were the rate of improvement, the rate of recurrence, and the rate of fecal incontinence.</p><p><strong>Results: </strong>Cure, incontinence, and recurrence rates were 68% (95% CI, .60-.76), 27% (95% CI, .12-.46), and 18% (95% CI, .12-.26), respectively. The pooled improvement ratio in patients treated with PRP compared to control group was 1.35 times, which was statistically significant (pooled OR=1.35, 95% CI, 1.14-1.60, <i>P</i><001). The pooled recurrence ratio in patients treated with PRP compared to control group was 1.17, which was not statistically significant (pooled OR=1.17, 95% CI, 0.44-3.11).</p><p><strong>Discussion: </strong>Platelet-rich plasma is an effective method of healing people with anal fistula.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11316947/pdf/","citationCount":"0","resultStr":"{\"title\":\"Efficacy and safety of autologous platelet-rich plasma in anal fistula: a systematic review and meta-analysis.\",\"authors\":\"Yuanhui Xu, Lin Ma, Keliang Jia, Xiaoling Wu, Chang Ge\",\"doi\":\"10.5144/0256-4947.2024.264\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>This study aimed to determine the efficacy and safety of autologous PRP in anal fistula.</p><p><strong>Methods: </strong>The search was done in electronic databases such as; PubMed, Scopus, Google Scholar, Embase, and Cochrane Library. The outcomes investigated in this study were the rate of improvement, the rate of recurrence, and the rate of fecal incontinence.</p><p><strong>Results: </strong>Cure, incontinence, and recurrence rates were 68% (95% CI, .60-.76), 27% (95% CI, .12-.46), and 18% (95% CI, .12-.26), respectively. The pooled improvement ratio in patients treated with PRP compared to control group was 1.35 times, which was statistically significant (pooled OR=1.35, 95% CI, 1.14-1.60, <i>P</i><001). The pooled recurrence ratio in patients treated with PRP compared to control group was 1.17, which was not statistically significant (pooled OR=1.17, 95% CI, 0.44-3.11).</p><p><strong>Discussion: </strong>Platelet-rich plasma is an effective method of healing people with anal fistula.</p>\",\"PeriodicalId\":93875,\"journal\":{\"name\":\"Annals of Saudi medicine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11316947/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of Saudi medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5144/0256-4947.2024.264\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/8/1 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Saudi medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5144/0256-4947.2024.264","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/1 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

简介:本研究旨在确定自体PRP治疗肛瘘的有效性和安全性:本研究旨在确定自体 PRP 治疗肛瘘的有效性和安全性:在 PubMed、Scopus、Google Scholar、Embase 和 Cochrane Library 等电子数据库中进行了搜索。本研究调查的结果为痊愈率、复发率和大便失禁率:治愈率、大便失禁率和复发率分别为 68% (95% CI, .60-.76)、27% (95% CI, .12-.46) 和 18% (95% CI, .12-.26)。与对照组相比,使用富血小板血浆治疗的患者的总改善率为 1.35 倍,具有统计学意义(总 OR=1.35,95% CI,1.14-1.60,PDiscussion:富血小板血浆是治愈肛瘘患者的有效方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Efficacy and safety of autologous platelet-rich plasma in anal fistula: a systematic review and meta-analysis.

Introduction: This study aimed to determine the efficacy and safety of autologous PRP in anal fistula.

Methods: The search was done in electronic databases such as; PubMed, Scopus, Google Scholar, Embase, and Cochrane Library. The outcomes investigated in this study were the rate of improvement, the rate of recurrence, and the rate of fecal incontinence.

Results: Cure, incontinence, and recurrence rates were 68% (95% CI, .60-.76), 27% (95% CI, .12-.46), and 18% (95% CI, .12-.26), respectively. The pooled improvement ratio in patients treated with PRP compared to control group was 1.35 times, which was statistically significant (pooled OR=1.35, 95% CI, 1.14-1.60, P<001). The pooled recurrence ratio in patients treated with PRP compared to control group was 1.17, which was not statistically significant (pooled OR=1.17, 95% CI, 0.44-3.11).

Discussion: Platelet-rich plasma is an effective method of healing people with anal fistula.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信